UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056957
Receipt number R000065091
Scientific Title Retrospective observational study on the efficacy of PuraStat in preventing delayed bleeding after endoscopic treatment of the gastrointestinal tract
Date of disclosure of the study information 2025/02/06
Last modified on 2025/02/06 16:56:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Retrospective observational study on the efficacy of PuraStat in preventing delayed bleeding after endoscopic treatment of the gastrointestinal tract

Acronym

R-PPE

Scientific Title

Retrospective observational study on the efficacy of PuraStat in preventing delayed bleeding after endoscopic treatment of the gastrointestinal tract

Scientific Title:Acronym

R-PPE

Region

Japan


Condition

Condition

Cases in which PuraStat was used during endoscopic resection of gastrointestinal tumors with a particularly high risk of delayed bleeding (cases in which the patient was taking antithrombotic medication, cases in which endoscopic resection of the duodenal bulb was performed and suture was not performed), cases in which PuraStat was used for gastroduodenal ulcer bleeding, cases in which PuraStat was used for bleeding after endoscopic treatment PuraStat was used for delayed bleeding after endoscopic treatment.

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine whether PuraStat can prevent delayed bleeding after endoscopic procedures

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incidence of delayed bleeding will be calculated and compared with previously reported cases and cases without PuraStat under similar conditions at our hospital.

Key secondary outcomes

Rate of delayed perforation, difference in rate of delayed bleeding by treatment site (duodenal vs. other), postoperative course, medical costs (calculated from devices used, labor costs, hospitalization costs, etc.)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Cases in which PuraStat was used during endoscopic resection of gastrointestinal tumors with a particularly high risk of delayed bleeding (cases in which patients were taking antithrombotic medications, cases in which endoscopic resection of the duodenal bulb was performed and suture was not performed), cases in which PuraStat was used for gastroduodenal ulcer bleeding, cases in which PuraStat was used for bleeding after endoscopic treatment PurStat was used for delayed bleeding after endoscopic treatment.

Key exclusion criteria

Cases in which the use of PuraStat was discontinued due to allergic reaction to PuraStat, etc., cases in which other hemostatic agents were used concomitantly, cases with hematological diseases, and cases in which refusal to participate in the study was made by the patient or his/her representative.

Target sample size

110


Research contact person

Name of lead principal investigator

1st name Motohiko
Middle name
Last name Kato

Organization

Keio University Hospital

Division name

Center for Diagnostic and Therapeutic Endoscopy

Zip code

1608582

Address

35, Shinanomachi, Shinjuku-ku, Tokyo

TEL

0333531211

Email

motohikokato@keio.jp


Public contact

Name of contact person

1st name Atsushi
Middle name
Last name Nakayama

Organization

Keio University Hospital

Division name

Cancer Center

Zip code

1608582

Address

35, Shinanomachi, Shinjuku-ku, Tokyo

TEL

0333531211

Homepage URL


Email

anakayama34@keio.jp


Sponsor or person

Institute

Keio University Hospital

Institute

Department

Personal name



Funding Source

Organization

3-D Matrix, Inc.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics committee of Keio university school of medicine

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

Tel

0333531211

Email

med-rinri-ft_pt@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 02 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 06 Month 25 Day

Date of IRB

2024 Year 06 Month 25 Day

Anticipated trial start date

2024 Year 06 Month 25 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2025 Year 02 Month 06 Day

Last modified on

2025 Year 02 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065091